Non-Current Assets
Indefinite-Lived Trademarks
Boston Scientific Indefinite-Lived Trademarks decreased by 5.3% to $770.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 719.1%, from $94.00M to $770.00M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Trademarks shows an upward trend with a 16.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID:
indefinite_lived_trademarksHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $330.00M | $374.00M | $246.00M | $246.00M | $232.00M | $232.00M | $232.00M | $232.00M | $174.00M | $174.00M | $174.00M | $174.00M | $214.00M | $94.00M | $94.00M | $94.00M | $813.00M | $813.00M | $813.00M | $770.00M |
| QoQ Change | — | +13.3% | -34.2% | +0.0% | -5.7% | +0.0% | +0.0% | +0.0% | -25.0% | +0.0% | +0.0% | +0.0% | +23.0% | -56.1% | +0.0% | +0.0% | +764.9% | +0.0% | +0.0% | -5.3% |
| YoY Change | — | — | — | — | -29.7% | -38.0% | -5.7% | -5.7% | -25.0% | -25.0% | -25.0% | -25.0% | +23.0% | -46.0% | -46.0% | -46.0% | +279.9% | +764.9% | +764.9% | +719.1% |
Range$94.00M – $813.00M
CAGR+19.5%
Avg YoY Growth+139.7%
Median YoY Growth-25.0%
Indefinite-Lived Trademarks at Other Companies
Frequently Asked Questions
- What is Boston Scientific's indefinite-lived trademarks?
- Boston Scientific (BSX) reported indefinite-lived trademarks of $770.00M in Q1 2026.
- How has Boston Scientific's indefinite-lived trademarks changed year-over-year?
- Boston Scientific's indefinite-lived trademarks increased by 719.1% year-over-year, from $94.00M to $770.00M.
- What is the long-term trend for Boston Scientific's indefinite-lived trademarks?
- Over 5 years (2020 to 2025), Boston Scientific's indefinite-lived trademarks has grown at a 16.6% compound annual growth rate (CAGR), from $377.00M to $813.00M.